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ABSTRACT: A concise route towards two advanced fragments in the context of the total synthesis of the unique natural product 
azamerone is reported. Key synthetic features include the enantioselective synthesis of an epoxysilane and its Lewis acid induced 
cyclization and the installation of the pyridazine ring via a formylation/condensation sequence. This route provides strategic in-
sights into the chemistry of phtalazinediols, facilitating synthetic approaches towards this class of natural products.      
Over the last years, marine-sediment derived bacteria of the 
order of Actinomycetales (= actinomycetes) have been recog-
nized as a valuable source for the discovery of novel, structur-
ally unique natural products with interesting biological activi-
ty,[1,2] such as antibacterial,[2] anticancer[3] and anti-infective[4] 
properties. As an example of this chemical diversity, these 
organisms are producing a family of halogenated natural prod-
ucts called napyradiomycins, of which there are over 40 
known members.[5] Surprisingly, only the total synthesis of 
one member of this class, namely napyradiomycin A1, has 
been reported,[6] and very recently, Moore and co-workers 
published the total enzyme synthesis of napyradiomycins A1 
and B1.[7] In 2006, Fenical and co-workers isolated a new 
member of this class, which could be identified as the unusual 
meroterpenoid phtalazinone azamerone (1).[8] Besides pyri-
dazomycin, azamerone (1) constitutes the only natural product 
containing a pyridazine-ring, making it a very interesting 
target for total synthesis within this family of natural prod-
ucts.[9] In contrast to the biosynthesis of pyridazomycin,[9] in 
which the N–N bond has been suggested to be formed through 
the cyclization of L-ornithine, the group of Moore could pro-
vide evidence that this is not the case for azamerone (1).[10] 
Isolation of co-produced polyhalogenated meroterpenoids and 
analogues containing a diazo-functionality (2, 3) strongly 
suggest that the N–N bond in azamerone (1) is formed via an 
oxidative rearrangement of the diazo-functionality of com-
pound 3.[10] This could be verified by 15N and 13C labelling 
studies.[10] 
In the context of our interest in N–N bond containing natu-
ral products,[11] the structurally unique phtalazinone core of 
azamerone (1), the interesting halogenation pattern, and the 
highly functionalized cyclohexane side-chain, we selected this 
unique natural product as a challenging target for total synthe-
sis. 
Our retrosynthesis of azamerone (1) aimed at disconnecting 
the bond between cyclohexane unit 4 and the tricyclic phtala-
zinedione 5, which we envisioned to install late stage via a 
metal–mediated C–C bond-forming reaction (Scheme 1). 
Interestingly, Burns and co-workers recently and independent-
ly disclosed a similar strategy by employing a cyclic boronic 
hemiester and an azoquinone, which successfully lead to the 
total synthesis of azamerone (1).[12] The acetyl side-chain of 
azamerone (1) would be installed via a protecting group di-
rected, regioselective lithiation of the pyridazine-ring of tricy-
cle 6 followed by trapping with aldehyde, to produce tricyclic 
structure 5. The pyridazine ring in turn would be formed by a 





















































































































































to  bicycle 7 as a suitable starting  material for  our synthetic 
endeavors.  
Our synthesis  of  key  bicyclic  hydroquinone 7 (Scheme  2) 
started with a three step sequence,[13] which delivered protect-
ed intermediate 8 in  high  yield from commercialy available 
2,5-dimethoxybenzaldehyde (9).  Unfortunately,  deprotection 
of the  methyl-groups  under standard conditions (BBr3,  BCl3, 
AlCl3) led only to decomposition.[14] 
Scheme 2. Synthesis of the core structure of azamerone (1). 
 
However,  oxidative  demethylation  using [bis(trifluoro-
acetoxy)iodo]benzene (PIFA) in acetonitrile/water (2:1,  v/v) 
aforded the coresponding para-quinone in  good yield.[15] 
Subsequent reduction  using in situ generated sodium tri-
acetoxyborohydride aforded  hydroquinone 7 in  89%  yield. 
With this intermediate in  hand,  we set  out to investigate the 
key three step sequence for instaling the  pyridazine-ring  of 
the  natural  product.  Upon treatment  of  hydroquinone 7 with 
piperidine and aqueous formaldehyde solution, the  desired 
diaminoalkylation  was  observed,  delivering compound 10 in 
75% yield.[16] The reaction of 10 in acetic acid with a solution 
of chromium(VI)  oxide in acetic acid/water (1:1,  v/v) fur-
nished  desired  diformyl  dihydroquinone 11.[17] Ring closure 
was then afected  by condensation  with  hydrazine  hydrate, 
which led to pyridazine core structure 12 in 88% yield. How-
ever, tricycle 12 proved to be prone to oxidation, which leads 
to the formation of quinone 13 in trace amounts upon column 
chromatography.  Ful conversion to intermediate 13 was  ob-
served after 20 h under an oxygen atmosphere. 
With these promising results in hand, we set out to investi-
gate the introduction  of the acetyl side-chain.  Regioselective 
protection of the hydroxy-group at position C-10 of tricycle 12 
proved to be chalenging due to decomposition of the product 
in the reaction mixture. After extensive experimentation, suit-
able conditions were identified, which involved a large excess 
(10 equiv)  of tri-iso-propylsilyl chloride (TIPSCl) and 4-
(dimethylamino)pyridine (DMAP) as a catalyst and  base, 
which furnished the desired regioisomer 14, as unambiguously 
shown by X-ray crystalography, in 74% yield. 
However,  when treating the  mono-TIPS  protected  hydro-
quinone 14 with a  base (NEt3,  NaH,  LiHMDS,  K2CO3) fol-
lowed  by an electrophile (MOMBr,  MEMCl,  Me3OBF4) 
dearomatization was observed, leading to the sole isolation of 
dearomatized,  nitrogen-protected compounds  of the  general 
structure 15 in up to 50% yield on 10 mg scale. The structure 
was confirmed by X-ray analysis of the MOM protected tricy-
cle 16 (Scheme 2). Increasing the scale to 50 mg resulted in a 
drastic  drop in  yield and additionaly, migration  of the  TIPS 
group could be observed in trace amounts.  
Scheme 3. Tandem diborylation-double alylation. 
 
In  paralel,  we turned  our atention to the enantioselective 
synthesis of the cyclohexane unit of azamerone (1). Previous-
ly,  Snyder and co-workers  developed a chloronium-induced 
cyclization  method for the synthesis  of a  precursor  of the 
cyclohexane  unit.[18,19] However, this reaction  delivered  only 
racemic material, rendering a tedious separation via resolution 
mandatory.[18]  Thus, our first approach sought to employ the 
enantioselective, catalytic diborylation-double alylation strat-
egy developed by the group of Morken.[20] 
To explore the feasibility  of this approach,  we synthesized 
diene 17 in three steps from phosphorous ylide 18.[21] Witig 
olefination  with acrolein furnished  diene 19,  which could  be 
reduced to primary alcohol 20 using DIBAL-H.[21] Protection 
of the primary hydroxy group with tert-butyl(chloro)diphenyl-
silane (TBDPSCl) then furnished silyl ether 17. Oxidation of 
5-hydroxy-2-pentanone (21)  using (diacetoxyiodo)benzene 
(PIDA) and (2,2,6,6-tetramethylpiperidin-1-yl)oxyl (TEMPO) 
aforded dicarbonyl 22.[20] We then turned our atention to the 
key tandem  diborylation-double alylation reaction.  Gratify-
ingly, the enantioselective Pt-catalyzed diboration of diene 17 
with bis(pinacolato)diboron (B2pin2) using Pt(dba)3 as a cata-
lyst and a TADDOL-derived ligand, folowed by in situ trap-
ping  of the  diborylated species  with  dicarbonyl 22 delivered 
cyclohexane 23 in 60% yield with a d.r. of 9:1 (as judged by 
1H-NMR at position C1) (Scheme 3) and 88% ee. The relative 
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configuration was validated by deprotection of the silyl ether 
by using TBAF to afford triol 24, from which a suitable crystal 
for an X-ray crystal structure determination could be obtained. 
With these results, we set out to explore the deoxygenation of 
the primary hydroxy-group. However, even after employing a 
large variety of conditions, this was not successful. Instead of 
the formation of the desired compound 25, the main byprod-
ucts observed included oxetane formation (I2, PPh3, imH), or 
thiocarbonate formation (TCDI, NEt3, DMAP), when trying to 
install a thiocarbonylimidazole precursor for radical deoxy-
genation. Based on these results we decided to focus on a 
different strategy, which utilizes the Lewis acid induced cy-
clization of epoxysilanes (Scheme 4). 
 
Scheme 4. Enantioselective synthesis of cyclohexane unit.  
 
Starting from methyl acetoacetate (26), epoxysilane 27 
could be prepared in an enantiomerically enriched form in five 
linear steps.[22] Upon treatment with boron trifluoride etherate, 
the Lewis acid induced cyclization of epoxide 27 could be 
achieved to give cyclohexane 28.[22] TBS-protection of the 
secondary hydroxy group furnished silyl ether 29. This group 
was envisioned to shield the back face of compound 4, thus 
enhancing the diastereoselectivity in the key C–C bond for-
mation to the tricyclic core of azamerone (1). Epoxidation 
using m-CPBA and sodium bicarbonate afforded a 4:1 mixture 
of diastereomers, favoring the desired epoxide 30, which was 
verified by X-ray crystallography after separation of the dia-
stereomeric mixture. Finally, global reduction of epoxide 30 
afforded diol 4. This cyclohexane-unit has all required stereo-
centers in place and can be seen as a suitable partner for cou-
pling with the core structure of azamerone (1), for example via 
a similar strategy to that employed by the Burns group.[12] 
Herein we report the successful synthesis of two advanced 
fragments, which can be utilized in the total synthesis of 
azamerone (1). The synthesis relies on the cyclization of 
epoxysilane 27 and the rapid synthesis of the tricyclic core of 
the natural product via an aminoalkylation-oxidation-
condensation sequence. In contrast to previous methods re-
ported for the synthesis of the cyclohexane unit, the cycliza-
tion of epoxysilanes such as 27 establishes an enantioselective 
approach to the complex substitution pattern of the side chain 
of azamerone (1).  
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